Skip to content

Crestline Management, L.P.

Follow

13F filer, CIK 1536054, FORT WORTH, TX

Crestline Management, L.P. reported $58,088,757 across 3 holdings for the quarter ended 2025-09-30, in a 13F-HR filed 2025-11-14.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001315863-25-000800

Period
2025-09-30
Reported value
$58.1M
Holdings
3
Top 10 weight
100%
New
0
Sold out
0

Largest buys vs the previous quarter

None.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
DNLIreduced-450,000-$6.53M
SANAreduced-600,000-$2.13M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2025

Share positions as resolved from 13F-HR 0001315863-25-000800, largest first. % of portfolio is the value over $58,088,757, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
DNLIDENALI THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 4,460,732 shares; 2024Q4: 4,310,732 shares; 2025Q1: 4,160,732 shares; 2025Q2: 3,860,732 shares; 2025Q3: 3,410,732 shares 3,410,732$49.5M85.26%-450,000Timeline
SANASANA BIOTECHNOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 3,085,624 shares; 2024Q4: 2,860,937 shares; 2025Q1: 2,790,937 shares; 2025Q2: 2,420,937 shares; 2025Q3: 1,820,937 shares 1,820,937$6.46M11.13%-600,000Timeline
EGHT8X8 INC NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 998,380 shares; 2024Q4: 998,380 shares; 2025Q1: 990,580 shares; 2025Q2: 990,580 shares; 2025Q3: 990,580 shares 990,580$2.1M3.62%0Timeline

How Q3 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001315863-25-000800 base2025-11-14acceptance time not in the bulk data set